Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool January 29, 2008 Brian Lawler	BioSante's Gamble Against Generics BioSante releases more information on the pivotal studies for its lead drug.
The Motley Fool April 30, 2007 Mike Havrilla	VIVUS Revives Investor Interest New drugs with huge markets could keep shares of VIVUS on their upward trajectory.
The Motley Fool May 14, 2007 Brian Lawler	Biosante's Lame Deal Last week, shares of the drugmaker were up 8% after the company announced that it had signed a drug development deal with a tiny European pharma, Pantarhei.
Salon.com July 10, 2002 Trisha Posner	Death by hormones It's been more than 50 years since studies first sounded the alarm about hormone replacement therapy. Women, silenced by shame, have been guinea pigs of the pharmaceutical industry for too long.
The Motley Fool September 17, 2007 Brian Orelli	Preventing Cancer, No Bones About It For Eli Lilly, the only thing better than having a drug with more than $1 billion in annual sales is getting it approved to treat more patients. That's what just happened with their cancer drug, EVISTA. Investors, take note.
The Motley Fool December 15, 2011 Anders Bylund	BioSante Pharmaceuticals' Shares Died: What You Need to Know Is this meaningful, or just another movement for BioSante Pharmaceuticals?
American Family Physician March 15, 2004	Breast Cancer Risk Related to Type of Hormone Therapy Although several studies have demonstrated an increased risk of breast cancer in postmenopausal women taking oral hormone therapy, the risk related to each of the various forms of therapy is less clear.
The Motley Fool December 3, 2004 Charly Travers	Sex Patch Returns to Lab FDA panel's safety concerns have sidetracked Proctor & Gamble's Intrinsa.
American Family Physician December 15, 2005 Janelle Guirguis-Blake	Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women The case study and answers to the following questions on hormone therapy for the prevention of chronic conditions in postmenopausal women are based on the recommendations of the U.S. Preventive Services Task Force (USPSTF).
The Motley Fool December 14, 2011 David Williamson	BioSante Investors: It Was Nice While It Lasted Libigel loses to placebo in two studies, shares down 75% after hours.
American Journal of Nursing June 2011 Karen Roush	Menopausal Hormone Therapy: What We Know Now This article describes the findings and limitations of the major research thus far on hormone therapy.
Health August 24, 2009 Catherine Guthrie	The Latest on Hormone Therapy for Women It's not often that a middle-aged former sitcom star is at the center of an important health debate. But Suzanne Somers's hormone therapy -- has put her in the limelight.
Reactive Reports Issue 53 David Bradley	An Underarm Review A review of health effects of organometallic compounds suggests that aluminum compounds used in the manufacture of underarm antiperspirants may somehow be involved in an increased risk of breast cancer.
Nurse Practitioner July 2011 Kass-Wolff & Fisher	Menopause and the Hormone Controversy: Clarification or Confusion? Hormone therapy in perimenopause and menopause remains a controversial and often confusing management strategy for healthcare providers. To assist in providing women quality healthcare, recently published new guidelines help provide direction for NPs.
BusinessWeek June 26, 2006 Arlene Weintraub	Homegrown Hormone Therapy: How Safe? Popular alternatives to menopause drugs are under fierce attack by Wyeth and others.
Managed Care June 2002	Oncologists: FDA needs to speed up approval of cancer-fighting drugs A Competitive Enterprise Institute survey of cancer specialists found that almost 8 of 10 oncologists think the FDA's approval process has "hurt their ability, at least once in their medical careers, to treat patients with the best possible care."
The Motley Fool May 8, 2009 Brian Orelli	Investing Against Breast Cancer Many companies are interested in both a cure and a large lucrative market. Which are the best investments now in this sector?
The Motley Fool January 28, 2005 Karl Thiel	Will the FDA Kill Biotech? Proposed legislation could spell changes across the pharmaceutical world. Investors are right to be nervous.
BusinessWeek July 3, 2006 Catherine Arnst	A Ton Of Prevention The pros and cons of two drugs that may halve your risk of breast cancer.
AskMen.com September 30, 2000 Joshua Levine	Male Breast Cancer Breast cancer is traditionally thought of as a female-related problem. Men, however, are as susceptible to the disease as women are. In many ways, the disease appears similarly in both sexes...
Chemistry World February 23, 2009 Nina Notman	Resistant breast cancers re-sensitised to Tamoxifen A way to re-sensitise certain drug-resistant breast cancers to treatments such as Tamoxifen could offer better treatment for people with hard-to-beat cancers.
BusinessWeek June 6, 2005 Catherine Arnst	Better Odds Against Breast Cancer New treatments for breast cancer are more effective, and easier to live with
The Motley Fool May 31, 2007 Brian Lawler	Bradley Offers to Buy Itself The drugmaker's CEO offers to take the company private. But are all buyout offers a good deal for shareholders?
BusinessWeek May 23, 2005 Catherine Arnst	If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer.
American Family Physician March 15, 2004	Transdermal Estrogen and Venous Thromboembolism Oral estrogen therapy has been associated with increased risk of venous thromboembolism in postmenopausal women in observational studies and randomized controlled trials.
American Family Physician March 1, 2004	Osteoporosis The definition, signs, and who's at risk of getting osteoporosis.
The Motley Fool January 17, 2012 Subhadeep Ghose	Why Vera Bradley Has Reason to Be Cautious Vera Bradley's third-quarter results are impressive but outlook is guarded.
CFO October 1, 2009 Sarah Johnson	Buying Cash That was one CFO's solution for keeping his small company afloat as it waits for regulatory approval of its product and continues to burn through funds.
Science News August 3, 2002 Janet Raloff	Surprise! Obesity (and inactivity) can spur cancers Some 60 percent of U.S. adults say they're worried at the prospect of developing cancer, yet only 6 percent recognize that being overweight is a leading predisposing factor.
American Family Physician March 15, 2001 Jeannette E. South-Paul	Osteoporosis: Part II. Nonpharmacologic and Pharmacologic Treatment Family physicians will frequently encounter patients with osteoporosis, a condition that is often asymptomatic until a fracture occurs...
American Family Physician August 1, 2000 Lecia M. Apantaku	Breast Cancer Diagnosis and Screening Statistics on breast cancer risk, symptoms and recommended tests.
AskMen.com Sabrina Rogers	Can Men Get Breat Cancer? Breast cancer isn't just a chick thing. Although it is about 100 times more common among women and is a rare cause of death in men, the American Cancer Society estimates that, in 2004, approximately 1,450 American men will be diagnosed with this disease.
The Motley Fool December 27, 2010 Brian D. Pacampara	BioSante Pharmaceuticals Shares Popped: What You Need to Know Shares of BioSante Pharmaceuticals, which develops products for female sexual health and oncology, soared a staggering 28% in intraday trading on extraordinarily high volume.